Annual report pursuant to Section 13 and 15(d)

STOCK OPTIONS AND WARRANTS (Details Narrative)

v3.23.1
STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)
 12 Months Ended
Jun. 08, 2022
May 05, 2022
Dec. 31, 2022
Dec. 31, 2021
Stock price     $ 0.975  
Stock compensation expense     $ 111,079 $ 8,715
Stock compensation expense unamortized     $ 13,269  
Weighted average remaining life     17 months  
Fair value of warrants     $ 86,821  
Purchase of common stock, shares     48,309  
Number of stock option shares, vested     59,057  
Consultant [Member]        
Number of stock option shares, vested     14,000  
Stock option     $ 31,374  
Director [Member]        
Number of stock option shares, vested     45,057  
Stock option     $ 92,973  
DeCsepel 2022 Subscription Agreement | Warrant [Member]        
Purchase of common stock, shares   165,929    
Common stock, par value   $ 0.001    
Aggregate warrant amount   $ 250,000    
Purchase price, per share   $ 2.26    
Common stock shares issued   110,619    
Exercise price   $ 6.00    
Plan termination term   3 years    
2014 Equity Incentive Plan [Member]        
Common stock shares issued     290,879  
Number of stock option shares, vested     145,000  
Option grantable     145,879  
Percent of issued and outstanding shares     20.00%  
2016 Equity Incentive Plan [Member]        
Common stock shares issued     656,250  
Number of stock option shares, vested     330,350  
Option grantable     325,900  
2018 Equity Incentive Plan [Member]        
Common stock shares issued     450,000  
Number of stock option shares, vested     380,008  
Option grantable     69,992  
2022 Equity Incentive Plan [Member]        
Common stock shares issued     695,000  
Number of stock option shares, vested     42,330  
Option grantable     652,670  
Kent Emry [Member]        
Fair value of warrants $ 214,975   $ 214,975  
Purchase of common stock, shares     119,617